Tetra Bio-Pharma hopes $6M raise carries firm through to revenue stage
Orléans-based company has spent years developing drugs designed to mimic the pain-killing and anti-inflammatory benefits of cannabis without major side effects.
Tetra Bio-Pharma hopes $6M raise carries firm through to revenue stage
Orléans-based company has spent years developing drugs designed to mimic the pain-killing and anti-inflammatory benefits of cannabis without major side effects.
Get up-to-date news about the companies, people and issues that impact businesses in Ottawa and beyond.
Sponsored
Didn’t we just do this? More changes coming to the Ontario Construction Act
Do I need an engineer for my construction project?
EVENT ALERT: Mayor's Breakfast with Ontario Finance Minister on Wednesday, Dec. 4 @ City Hall